• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎中的左旋咪唑——一项多中心研究的多变量分析

Levamisole in rheumatoid arthritis--a multivariate analysis of a multicentric study.

作者信息

Lewi P J, Symoens J

出版信息

J Rheumatol Suppl. 1978;4:17-25.

PMID:366138
Abstract

Statistical analysis of the data from a multicentric study of six months of treatment with levamisole in rheumatoid arthritis involved two steps. In a first step, the differences between observations before and after treatment have been made independent of their initial values. Differences after treatment have been transformed into responses to treatment using a proportionality factor that is related to the initial values before treatment. The second step involved a reduction of the various responses into a single global response by means of a discriminant analysis between two classes. Class membership has been defined by the type of treatment (either placebo or drug) predicted by the investigators at the end of treatment and before breaking of the code of the double-blind study. This method of analysis allows for the combination of multiple clinical observations with a subjective evaluation. Its results can be easily represented graphically and tested for statistical significance. The use of global responses to treatment is illustrated with a comparison of placebo and drug treatments and can be extended to comparisons between investigators or between different dose and time regimens.

摘要

对类风湿性关节炎患者使用左旋咪唑进行为期六个月的多中心研究的数据进行统计分析包括两个步骤。第一步,治疗前后观察值之间的差异已与它们的初始值无关。治疗后的差异已通过与治疗前初始值相关的比例因子转化为对治疗的反应。第二步涉及通过两类之间的判别分析将各种反应简化为单一的总体反应。类别归属已根据研究人员在治疗结束时和双盲研究代码破解之前预测的治疗类型(安慰剂或药物)来定义。这种分析方法允许将多个临床观察结果与主观评估相结合。其结果可以很容易地用图形表示并进行统计学显著性检验。通过安慰剂和药物治疗的比较说明了对治疗总体反应的使用,并且可以扩展到研究人员之间或不同剂量和时间方案之间的比较。

相似文献

1
Levamisole in rheumatoid arthritis--a multivariate analysis of a multicentric study.类风湿关节炎中的左旋咪唑——一项多中心研究的多变量分析
J Rheumatol Suppl. 1978;4:17-25.
2
Double-blind placebo-controlled evaluation of levamisole in chronic rheumatoid arthritis.
Scand J Rheumatol. 1979;8(1):43-8.
3
Degree of responsiveness to levamisole and factors influencing responsiveness and adverse reactions.对左旋咪唑的反应程度以及影响反应性和不良反应的因素。
J Rheumatol Suppl. 1978;4:26-30.
4
Experience and recommendations for treatment schedule of levamisole in rheumatoid arthritis.类风湿关节炎中左旋咪唑治疗方案的经验与建议
J Rheumatol Suppl. 1978;4:31-41.
5
A double-blind comparison of high and low doses of levamisole in rheumatoid arthritis.
J Rheumatol. 1981 Nov-Dec;8(6):949-51.
6
Clinical and laboratory studies of levamisole in patients with rheumatoid arthritis.左旋咪唑用于类风湿性关节炎患者的临床及实验室研究。
Q J Med. 1978 Jul;47(187):385-400.
7
A multicentre randomized double-blind study comparing two dosages of levamisole in rheumatoid arthritis.一项比较两种剂量左旋咪唑治疗类风湿性关节炎的多中心随机双盲研究。
J Rheumatol Suppl. 1978;4:5-10.
8
International symposium on levamisole in rheumatoid arthritis. A review of short and longterm effects on articular manifestations.类风湿关节炎中左旋咪唑的国际研讨会。关于对关节表现的短期和长期影响的综述。
J Rheumatol Suppl. 1978;4:11-6.
9
Levamisole and cellular immunity in rheumatoid arthritis--clinical and laboratory correlates.左旋咪唑与类风湿关节炎中的细胞免疫——临床及实验室相关性
J Rheumatol Suppl. 1978;4:63-70.
10
[Controlled trial of levamisole in rheumatoid arthritis. Clinical and immunological study of 22 cases (author's transl)].左旋咪唑治疗类风湿关节炎的对照试验。22例临床与免疫学研究(作者译)
Nouv Presse Med. 1978 Oct 7;7(34):3023-7, 3029-30.

引用本文的文献

1
Alteration in lymphocyte phenotype associated with administration of adjuvant levamisole and 5-fluorouracil.与辅助使用左旋咪唑和5-氟尿嘧啶相关的淋巴细胞表型改变。
Cancer Immunol Immunother. 1994 Jun;38(6):394-8. doi: 10.1007/BF01517209.
2
Levamisole in rheumatoid arthritis. Final report on a randomised double-blind study comparing a single weekly dose of levamisole with placebo. Multicentre Study Group.左旋咪唑治疗类风湿性关节炎。比较每周单剂量左旋咪唑与安慰剂的随机双盲研究最终报告。多中心研究组。
Ann Rheum Dis. 1982 Apr;41(2):159-63. doi: 10.1136/ard.41.2.159.
3
Double-blind trial of dapsone against placebo in the treatment of rheumatoid arthritis.
氨苯砜治疗类风湿关节炎对比安慰剂的双盲试验。
Ann Rheum Dis. 1981 Jun;40(3):235-9. doi: 10.1136/ard.40.3.235.
4
Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis.类风湿关节炎患者接受胸腺生成素五肽(TP - 5)治疗的临床反应
Ann Rheum Dis. 1982 Oct;41(5):441-3. doi: 10.1136/ard.41.5.441.
5
A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.OM - 8980与金诺芬治疗类风湿关节炎的双盲多中心研究。
Ann Rheum Dis. 1988 Jul;47(7):582-7. doi: 10.1136/ard.47.7.582.
6
Follow-up with OM-8980 after a double-blind study of OM-8980 and auranofin in rheumatoid arthritis.在一项关于OM-8980和金诺芬治疗类风湿性关节炎的双盲研究之后对OM-8980进行随访。
Clin Rheumatol. 1990 Sep;9(3):356-61. doi: 10.1007/BF02114396.